These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10239681)

  • 1. Laser products: final rule.
    Fed Regist; 1978 Nov; 43(229):55387-93. PubMed ID: 10239681
    [No Abstract]   [Full Text] [Related]  

  • 2. Laser products; amendments to performance standard--FDA. Final rule.
    Fed Regist; 1985 Aug; 50(161):33682-702. PubMed ID: 10273688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(168):52302-5. PubMed ID: 11067736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; reclassification and codification of Neodymium:Yttrium:Aluminum:Garnet (Nd:YAG) Laser for peripheral iridotomy. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Feb; 65(29):6893-4. PubMed ID: 11010651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; partial stay of compliance. Food and Drug Administration, HHS. Final rule; partial stay of compliance.
    Fed Regist; 2000 Sep; 65(190):58346-50. PubMed ID: 11503646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(202):62282-5. PubMed ID: 11503680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May; 64(98):27666-93. PubMed ID: 10558542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingrown toenail relief drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 May; 68(88):24347-9. PubMed ID: 12737160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; laser fluorescence caries detection device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18234-6. PubMed ID: 11010622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; obstetrical and gynecological devices; classification of the assisted reproduction laser system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(248):77623-4. PubMed ID: 15624253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2005 May; 70(100):29949-52. PubMed ID: 15915582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Records and reports regulations for radiation emitting electronic products; correction--FDA. Final rule; correction.
    Fed Regist; 1996 Mar; 61(60):13421-4. PubMed ID: 10155828
    [No Abstract]   [Full Text] [Related]  

  • 17. NRC proposed amendments: too little, too late?
    Newman MA
    J Nucl Med; 1993 Sep; 34(9):25N. PubMed ID: 8355088
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.